Akl, M.R.; Foudah, A.I.; Ebrahim, H.Y.; Meyer, S.A.; Sayed, K.A.E.
The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling. Mar. Drugs 2014, 12, 2282-2304.
https://doi.org/10.3390/md12042282
AMA Style
Akl MR, Foudah AI, Ebrahim HY, Meyer SA, Sayed KAE.
The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling. Marine Drugs. 2014; 12(4):2282-2304.
https://doi.org/10.3390/md12042282
Chicago/Turabian Style
Akl, Mohamed R., Ahmed I. Foudah, Hassan Y. Ebrahim, Sharon A. Meyer, and Khalid A. El Sayed.
2014. "The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling" Marine Drugs 12, no. 4: 2282-2304.
https://doi.org/10.3390/md12042282
APA Style
Akl, M. R., Foudah, A. I., Ebrahim, H. Y., Meyer, S. A., & Sayed, K. A. E.
(2014). The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling. Marine Drugs, 12(4), 2282-2304.
https://doi.org/10.3390/md12042282
